US Stock MarketDetailed Quotes

CTNM Contineum Therapeutics

Watchlist
  • 7.070
  • -0.380-5.10%
Close Mar 28 16:00 ET
  • 7.070
  • 0.0000.00%
Post 16:00 ET
182.91MMarket Cap-4.33P/E (TTM)

Contineum Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-269.75%-32.85M
4.69%-10.2M
-14.73%-6.17M
-120.90%-8.5M
-52.08%-7.98M
196.16%19.35M
-162.61%-10.7M
-5.38M
40.67M
-5.24M
Net income from continuing operations
-285.99%-42.26M
-87.48%-14.57M
-64.25%-10.27M
-121.68%-9.01M
-74.48%-8.42M
193.68%22.72M
-3.42%-7.77M
---6.25M
--41.56M
---4.82M
Operating gains losses
507.14%85K
1,425.00%106K
----
----
387.50%117K
300.00%14K
-166.67%-8K
---2K
--0
--24K
Depreciation and amortization
32.31%258K
102.70%75K
44.19%62K
42.86%60K
-16.44%61K
-40.73%195K
-54.32%37K
--43K
--42K
--73K
Other non cash items
141.52%872K
-82.64%46K
-1.28%231K
112.26%351K
-7.58%244K
-172.46%-2.1M
-89.65%265K
--234K
---2.86M
--264K
Change In working capital
620.90%5.33M
205.73%2.95M
107.15%2.32M
-112.58%-209K
127.12%275K
19.18%-1.02M
-765.87%-2.79M
--1.12M
--1.66M
---1.01M
-Change in prepaid assets
169.46%887K
-1,541.67%-394K
135.11%435K
189.13%133K
1,288.33%713K
-237.83%-1.28M
-131.17%-24K
---1.24M
--46K
---60K
-Change in payables and accrued expense
116.06%3.44M
248.70%3.32M
-30.26%1.87M
-170.16%-1.29M
35.34%-450K
2,244.12%1.59M
-450.63%-2.23M
--2.68M
--1.84M
---696K
-Change in other current assets
13,285.71%937K
--0
101.67%1K
3,127.59%936K
--0
121.88%7K
203.13%33K
---60K
--29K
--5K
-Change in other current liabilities
104.90%66K
104.92%28K
104.96%13K
105.12%13K
104.56%12K
-45.73%-1.35M
19.63%-569K
---262K
---254K
---263K
Cash from discontinued investing activities
Operating cash flow
-269.75%-32.85M
4.69%-10.2M
-14.73%-6.17M
-120.90%-8.5M
-52.08%-7.98M
196.16%19.35M
-162.55%-10.7M
---5.38M
--40.67M
---5.24M
Investing cash flow
Cash flow from continuing investing activities
-6.36%-69.74M
-203.96%-9.39M
23.58%-30.18M
12.50%-38.9M
-6.67%8.73M
-394.04%-65.57M
83.65%9.03M
-39.5M
-44.46M
9.36M
Net PPE purchase and sale
-19.32%-494K
46.28%-166K
-181.82%-62K
-283.87%-119K
-182.69%-147K
-250.85%-414K
---309K
---22K
---31K
---52K
Net investment purchase and sale
-6.28%-69.25M
-198.75%-9.22M
23.69%-30.12M
12.71%-38.78M
-5.62%8.88M
-390.65%-65.15M
89.93%9.34M
---39.47M
---44.43M
--9.41M
Cash from discontinued investing activities
Investing cash flow
-6.36%-69.74M
-203.96%-9.39M
23.58%-30.18M
12.50%-38.9M
-6.67%8.73M
-394.04%-65.57M
83.65%9.03M
---39.5M
---44.46M
--9.36M
Financing cash flow
Cash flow from continuing financing activities
94.03%109M
300.00%642K
-99.87%13K
131.60%108.36M
97.08%-18K
4,633.98%56.18M
48.64%-321K
10.33M
46.79M
-617K
Net issuance payments of debt
--0
--0
--0
--0
--0
-200.00%-3.75M
--0
--0
---3.13M
---625K
Net common stock issuance
386,567.86%108.21M
--0
--0
----
----
-600.00%-28K
---28K
--0
----
----
Net preferred stock issuance
--0
--0
--0
----
----
--60.14M
--0
--10.24M
----
----
Proceeds from stock option exercised by employees
396.86%790K
1,184.00%642K
-84.15%13K
-31.58%13K
1,425.00%122K
960.00%159K
--50K
--82K
--19K
--8K
Net other financing activities
----
----
----
----
---140K
---343K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
94.03%109M
300.00%642K
-99.87%13K
131.60%108.36M
97.08%-18K
4,633.98%56.18M
48.64%-321K
--10.33M
--46.79M
---617K
Net cash flow
Beginning cash position
178.79%15.53M
133.38%40.89M
48.32%77.23M
79.45%16.26M
178.79%15.53M
20.28%5.57M
227.25%17.52M
--52.07M
--9.06M
--5.57M
Current changes in cash
-35.55%6.42M
-849.77%-18.95M
-5.18%-36.34M
41.76%60.97M
-78.88%738K
960.38%9.96M
-1,027.91%-2M
---34.55M
--43.01M
--3.49M
End cash Position
41.33%21.94M
41.33%21.94M
133.38%40.89M
48.32%77.23M
79.45%16.26M
178.79%15.53M
178.79%15.53M
--17.52M
--52.07M
--9.06M
Free cash flow
-276.18%-33.36M
5.86%-10.37M
-15.78%-6.25M
-121.20%-8.62M
-53.36%-8.12M
193.56%18.94M
-170.13%-11.01M
---5.4M
--40.64M
---5.3M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -269.75%-32.85M4.69%-10.2M-14.73%-6.17M-120.90%-8.5M-52.08%-7.98M196.16%19.35M-162.61%-10.7M-5.38M40.67M-5.24M
Net income from continuing operations -285.99%-42.26M-87.48%-14.57M-64.25%-10.27M-121.68%-9.01M-74.48%-8.42M193.68%22.72M-3.42%-7.77M---6.25M--41.56M---4.82M
Operating gains losses 507.14%85K1,425.00%106K--------387.50%117K300.00%14K-166.67%-8K---2K--0--24K
Depreciation and amortization 32.31%258K102.70%75K44.19%62K42.86%60K-16.44%61K-40.73%195K-54.32%37K--43K--42K--73K
Other non cash items 141.52%872K-82.64%46K-1.28%231K112.26%351K-7.58%244K-172.46%-2.1M-89.65%265K--234K---2.86M--264K
Change In working capital 620.90%5.33M205.73%2.95M107.15%2.32M-112.58%-209K127.12%275K19.18%-1.02M-765.87%-2.79M--1.12M--1.66M---1.01M
-Change in prepaid assets 169.46%887K-1,541.67%-394K135.11%435K189.13%133K1,288.33%713K-237.83%-1.28M-131.17%-24K---1.24M--46K---60K
-Change in payables and accrued expense 116.06%3.44M248.70%3.32M-30.26%1.87M-170.16%-1.29M35.34%-450K2,244.12%1.59M-450.63%-2.23M--2.68M--1.84M---696K
-Change in other current assets 13,285.71%937K--0101.67%1K3,127.59%936K--0121.88%7K203.13%33K---60K--29K--5K
-Change in other current liabilities 104.90%66K104.92%28K104.96%13K105.12%13K104.56%12K-45.73%-1.35M19.63%-569K---262K---254K---263K
Cash from discontinued investing activities
Operating cash flow -269.75%-32.85M4.69%-10.2M-14.73%-6.17M-120.90%-8.5M-52.08%-7.98M196.16%19.35M-162.55%-10.7M---5.38M--40.67M---5.24M
Investing cash flow
Cash flow from continuing investing activities -6.36%-69.74M-203.96%-9.39M23.58%-30.18M12.50%-38.9M-6.67%8.73M-394.04%-65.57M83.65%9.03M-39.5M-44.46M9.36M
Net PPE purchase and sale -19.32%-494K46.28%-166K-181.82%-62K-283.87%-119K-182.69%-147K-250.85%-414K---309K---22K---31K---52K
Net investment purchase and sale -6.28%-69.25M-198.75%-9.22M23.69%-30.12M12.71%-38.78M-5.62%8.88M-390.65%-65.15M89.93%9.34M---39.47M---44.43M--9.41M
Cash from discontinued investing activities
Investing cash flow -6.36%-69.74M-203.96%-9.39M23.58%-30.18M12.50%-38.9M-6.67%8.73M-394.04%-65.57M83.65%9.03M---39.5M---44.46M--9.36M
Financing cash flow
Cash flow from continuing financing activities 94.03%109M300.00%642K-99.87%13K131.60%108.36M97.08%-18K4,633.98%56.18M48.64%-321K10.33M46.79M-617K
Net issuance payments of debt --0--0--0--0--0-200.00%-3.75M--0--0---3.13M---625K
Net common stock issuance 386,567.86%108.21M--0--0---------600.00%-28K---28K--0--------
Net preferred stock issuance --0--0--0----------60.14M--0--10.24M--------
Proceeds from stock option exercised by employees 396.86%790K1,184.00%642K-84.15%13K-31.58%13K1,425.00%122K960.00%159K--50K--82K--19K--8K
Net other financing activities -------------------140K---343K----------------
Cash from discontinued financing activities
Financing cash flow 94.03%109M300.00%642K-99.87%13K131.60%108.36M97.08%-18K4,633.98%56.18M48.64%-321K--10.33M--46.79M---617K
Net cash flow
Beginning cash position 178.79%15.53M133.38%40.89M48.32%77.23M79.45%16.26M178.79%15.53M20.28%5.57M227.25%17.52M--52.07M--9.06M--5.57M
Current changes in cash -35.55%6.42M-849.77%-18.95M-5.18%-36.34M41.76%60.97M-78.88%738K960.38%9.96M-1,027.91%-2M---34.55M--43.01M--3.49M
End cash Position 41.33%21.94M41.33%21.94M133.38%40.89M48.32%77.23M79.45%16.26M178.79%15.53M178.79%15.53M--17.52M--52.07M--9.06M
Free cash flow -276.18%-33.36M5.86%-10.37M-15.78%-6.25M-121.20%-8.62M-53.36%-8.12M193.56%18.94M-170.13%-11.01M---5.4M--40.64M---5.3M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Petroleo Brasileiro SA Petrobras
PBR
-0.07%
Vale SA
VALE
-1.28%
Ecopetrol
EC
-1.64%
Taylor Morrison Home
TMHC
-2.11%
KB Home
KBH
-2.50%

Unlock the Full List